Dea Belazi is the CEO and Co-founder of AscellaHealth, a global Healthcare & Specialty Pharmacy solutions organization. Prior to this, Dea held various leadership roles in companies such as AlchemiPharma, Crowdhealth, Eli Lilly and Company, Towers Watson, Source Healthcare Analytics, Wolters Kluwer Health, GSK, Independence Blue Cross, and Keystone Mercy Health Plan. Dea holds a MPH in Public Health from The Johns Hopkins University, a PharmD in Pharmacy from the University of Rhode Island, and a High School Diploma from SKHS.
Sign up to view 11 direct reports
Get started